Literature DB >> 10538334

A review of quality of life in Alzheimer's disease. Parts 1 and 2: Issues in assessing disease impact and drug effects.

M Greer, H Monteban.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10538334     DOI： 10.2165/00019053-199915060-00009

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  2 in total

Review 1.  A review of quality of life in Alzheimer's disease. Part 1: Issues in assessing disease impact.

Authors:  M D Walker; S S Salek; A J Bayer
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

Review 2.  A review of quality of life in Alzheimer's disease. Part 2: Issues in assessing drug effects.

Authors:  S S Salek; M D Walker; A J Bayer
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981
  2 in total
  1 in total

1.  A review of quality of life in Alzheimer's disease. Parts 1 and 2: Issues in assessing disease impact and drug effects.

Authors:  S P McKenna; L C Doward
Journal:  Pharmacoeconomics       Date:  1999-10       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.